Cancer type | Potential Cancer Markers | Source | References |
---|---|---|---|
Bladder Cancer | TACSTD2, EDIL-3, Mucin4, EPS8L2, α6-integrin, MUC-1, Basigin | Urine | [126] |
Breast cancer | Survivin, Survivin-2B, CEA, Ttumor antigen15-3 | Blood | |
Colorectal cancer | CEA | Blood | Â |
Lung cancer | EpCAM, EGFR, CEA, LRG-1 | Blood | |
Melanoma | CD63, Caveolin1, TYRP2, VLA-4, HSP70 | Blood | |
Nasopharyngeal cancer | LMP1, Galectin-9, BARF-1 | Blood, Saliva | [103] |
Ovarian cancer | Claudin-4, L1CAM, CD24, ADAM10, EMMPRIN, TGFβ1, MAGE3/6 | Blood | |
Pancreatic cancer | GPC1, MIF | Blood | |
Prostate cancer | Transmembrane, protease, Serine2-ETS, β-catenin, PCA3, PSA, PSMA, ITGA3, ITGB1, survivin, PTEN | Urine | |
Renal cell carcinoma | MMP-9, EMMPRIN, Carbonic anhydrase | Urine | [125] |
Spongioblastoma | EGFR-VIII, EGFR, PDPN, IDH1 | Blood | |
Stomach cancer | HER-2/neu, CCR6 | Blood | [119] |